Business
C21 Investments Reports Fourth Quarter and Fiscal Year End Financial Results
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced the filing of its audited financial statements and management discussion and analysis for its fourth quarter and fiscal year ending March 31, 2025, on SEDAR. The Company's financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). All currency is reported in U.S. dollars. The Company recently changed its fiscal repor
About this update from C21 Investments Inc
[{"type":"text","content":"Q4's Increased Revenue Driven By Same Store Sales Growth Across All Silver State Relief Dispensaries","length":104,"tagName":"p","attribs":{}},{"type":"text","content":"VANCOUVER, BC, June 23, 2025 /CNW/ - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced the filing of its audited financial statements and management discussion and analysis for its fourth quarter and fiscal year ending March 31, 2025, on SEDAR. The Company's financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period to a March 31st year-end (see news release dated August 1, 2024 for audited two-month stub period). With this change, the comparative period in our audited financial statements will not reflect the same calendar months.","length":802,"tagName":"p"},{"type":"image","alt":"C21 Investments Inc. Logo (CNW Group/C21 Investments Inc.)","displaySize":"","headline":null,"caption":"C21 Investments Inc. Logo (CNW Group/C21 Investments Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":106,"url":"https://media.zenfs.com/en/cnwgroup.com/c61b6c7cfeeb0d14d1042c6c2f67bc32"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Y0G4SV0ljChMTTdapErhtw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4NztjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/c61b6c7cfeeb0d14d1042c6c2f67bc32","width":400,"height":106}},"href":"https://mma.prnewswire.com/media/2716984/C21_Investments_Inc__C21_Investments_Reports_Fourth_Quarter_and.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Fourth Quarter Highlights (January 1, 2025 to March 31, 2025):","length":62,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $8.1 million - up 3% from Q3 – driven by same store sales growth across all dispensaries; State of Nevada sales were down 6.5% from the sequential comparative period1; Compared to the previously reported Q4 (ended Jan. 31, 2024), revenue grew by 24%","length":260,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross Margin of 45% - relatively flat from Q3","length":45,"tagName":"p"}]},{"val":[{"type":"text","content":"Income from O...